Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2022-12-16
Product name
Promalin
1.2.1 Relevant identified uses
Plant growth regulation. Agricultural use. For professional use only
supplier name
SUMITOMO CHEMICAL AGRO EUROPE S.A.S
Manufacturer Name
VALENT BIOSCIENCES LLC
Emergency telephone
+44 (0) 1235 239 670
Icons in SDS
Company Information
company name
VALENT BIOSCIENCES LLC
e-mail address of the competent person responsible for the Safety Data Sheet
sds@sumitomo-chemical.eu
GHS Information
Signal word
No signal word
Hazard Codes
Hazard statements (CLP)
H412
Hazard statements
Code
Statements
H412
Harmful to aquatic life with long lasting effects
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture
Product definition
Mixture Classification according to UK CLP/GHS Aquatic Chronic 3, H412
Signal word
No signal word.
Hazard statements
H412 - Harmful to aquatic life with long lasting effects.
Prevention
Not applicable.
Response
Not applicable.
Storage
Not applicable.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Hazardous Ingredients
Not applicable.
Supplemental label elements
EUH401 -To avoid risks to human health and the environment, comply with the instructions for use.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted with child-resistant fastenings : Not applicable.
Tactile warning of danger
Not applicable.
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to UK CLP/GHS Aquatic Chronic 3, H412 The product is classified as hazardous according to UK CLP Regulation SI 2019/720 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
